NCT02728778View on ClinicalTrials.gov

Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

October 31, 2019

Conditions
Borderline Personality Disorder
Interventions
DRUG

incobotulinumtoxin A

Application of botulinum toxin A into the forehead

PROCEDURE

Acupuncture

Application of acupuncture into the forehead

Trial Locations (2)

30625

Hannover Medical School, Hanover

Unknown

Asklepios Klinik Nord-Ochsenzoll, Hamburg

All Listed Sponsors
lead

Hannover Medical School

OTHER

NCT02728778 - Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD) | Biotech Hunter | Biotech Hunter